PAA 3.03% 17.0¢ pharmaust limited

Phase 3 Canines Lymphoma B Trial ( what to expect), page-67

  1. 722 Posts.
    lightbulb Created with Sketch. 1427
    ...This approval was after completion of a Phase 3 trial with 58 dogs...

    Makes our Phase 2 / 2b participant numbers (which are always smaller than for a Phase 3) look pefectly reasonable.

    Very encouraging and a great find kpax.

    And the similarities go on!

    https://hotcopper.com.au/data/attachments/3842/3842631-e45d13794a421a326c5283cee526b9ca.jpg
    https://markets.*.com/news/stocks/anivive-repurposes-veterinary-drug-gc376-for-covid-19-and-submits-pre-ind-to-fda-1029235346


 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.0¢
Change
0.005(3.03%)
Mkt cap ! $82.65M
Open High Low Value Volume
17.0¢ 18.0¢ 16.8¢ $151.1K 877.6K

Buyers (Bids)

No. Vol. Price($)
4 54714 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 371375 7
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.